Is Infrequent Serum Hormone Testing Failing Peri- & Menopause Care? A Real-Time, Case-Based Guide
Supporting Lung Health Through the Microbiome: A Practitioner's Guide to the Gut-Lung Axis
The gut and lungs may seem like separate systems, but emerging research shows they are in constant communication through immune pathways, microbial metabolites, and inflammatory signals, a connection known as the Gut–Lung Axis.
In this webinar, Dr. Kara Fitzgerald was joined by Dr. Vivek Lal, founder of resbiotic, to explore how disruptions in the gut microbiome can increase inflammation and contribute to respiratory challenges – and what practitioners can do to restore balance.
Together, they dove into:
- The molecular mechanisms behind gut-lung crosstalk
- Latest research on pro-inflammatory metabolites, leaky gut and respiratory health
- Key factors that drive dysfunction in the gut-lung axis
- Evidence-based strategies for optimal lung health & longevity
Watch the recording below:
Disclaimer: This webinar is for informational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider.
Dr. Vivek Lal
MD, FAAP, CEO and founder of resbiotic
Dr. C. Vivek Lal, MD, FAAP, is a double board-certified physician–scientist and innovator based in Birmingham, AL. He leads Clinical Innovation at UAB’s Marnix Heersink Institute and directs the Pulmonary Microbiome Lab. Trained in neonatology/perinatal medicine, he completed a research fellowship in pulmonary/vascular biology at UT Southwestern and an executive program in drug and device development at MIT.
As founder of Biostack Ventures, he launched ResBiotic Nutrition (CEO) and Alveolus Bio, and co-founded Urgent Care for Children. He serves on boards including the Microbiome Therapeutics Innovation Group and BIO Alabama.
